Skip to main content
MEDIPOSTCO.,LTD. logo

MEDIPOSTCO.,LTD. — Investor Relations & Filings

Ticker · 078160 ISIN · KR7078160009 KO Manufacturing
Open in API
Filings indexed 366 across all filing types
Latest filing 2023-08-16 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 078160

About MEDIPOSTCO.,LTD.

https://en.medi-post.co.kr/

MEDIPOST is a biotechnology company specializing in the research, development, and commercialization of stem cell therapeutics and regenerative medicine. The company focuses on addressing unmet medical needs for incurable diseases through its proprietary stem cell platform technology. Its core operations include a cord blood banking service and the development of allogeneic stem cell therapies. Key commercialized products include CARTISTEM®, a treatment for knee cartilage defects and osteoarthritis, and PNEUMOSTEM®, a preventive therapy for bronchopulmonary dysplasia in premature infants. The company's clinical pipeline features next-generation injectable treatments for conditions such as osteoarthritis and diabetic nephropathy.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Capital Increase Decision' (유상증자결정), which is a regulatory filing in South Korea. It specifically details a correction (정정신고) to a previously filed report concerning the allocation method for a rights offering. Since this document details the specific terms, pricing, and allocation rules of a capital change (share issuance) rather than just announcing the publication of a report, it falls under the 'Share Issue/Capital Change' category.
2023-08-16 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Medipost Co., Ltd., covering the period from January 1, 2023, to June 30, 2023. It contains detailed financial statements, business overviews, capital structure, and management discussions, which are characteristic of an interim financial report. It is not an announcement of a report, but the report itself, and it contains substantive financial data. H1 2023
2023-08-14 Korean
[기재정정]증권신고서(지분증권) (2023.10)
Audit Report / Information Classification · 95% confidence The document is a '증권신고서(지분증권) 정정신고' (Securities Registration Statement Amendment) filed by Medipost Co., Ltd. This is a formal regulatory filing submitted to the Financial Supervisory Service (FSS) in South Korea to correct information in a previously filed securities registration statement. It details specific amendments to business risks, use of funds, and research and development activities. As it is a formal regulatory filing for securities registration, it falls under the 'Regulatory Filings' category. Q1 2023
2023-08-08 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from MediPost Co., Ltd. regarding a decision to issue new shares (capital increase/rights offering). This is a formal regulatory filing submitted to the Financial Services Commission and the Korea Exchange, detailing the terms, pricing, and procedures for the capital increase. It falls under the category of share issuance and capital changes.
2023-07-25 Korean
증권신고서(지분증권) (2023.10)
Share Issue/Capital Change Classification · 100% confidence The document is a '증권신고서' (Securities Registration Statement) filed with the Financial Services Commission (FSC) in South Korea. It details a capital increase through a rights offering followed by a general public offering of unsubscribed shares (주주배정후 실권주 일반공모 유상증자). This document is a formal regulatory filing for capital raising activities, which falls under the 'Share Issue/Capital Change' category.
2023-07-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. This type of filing is a mandatory disclosure for major shareholders (often referred to as the '5% rule' or 'major shareholding notification') when there is a change in their ownership stake, including conversions of convertible bonds or changes in share counts. This falls under the category of Major Shareholding Notification.
2023-07-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.